33Indexed trials
mesh condition
Mood Disorders
Intelligence
Mood Disorders intelligence: 33 indexed trials, 7 recruiting studies, 28 sponsors across 9 countries.
7Recruiting
28Sponsors
9Countries
Leading sponsors
National Institute of Mental Health (NIMH)30 recruiting
University of North Carolina, Chapel Hill31 recruiting
University of Michigan20 recruiting
GlaxoSmithKline10 recruiting
Johns Hopkins University10 recruiting
Mayo Clinic11 recruiting
Hospices Civils de Lyon10 recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.10 recruiting
Shalvata Mental Health Center10 recruiting
St. Joseph's Healthcare Hamilton10 recruiting
University Hospital, Toulouse10 recruiting
H. Lundbeck A/S10 recruiting
Geographic activity
United States20trials
France3trials
Canada3trials
Australia2trials
China2trials
United Kingdom2trials
Russia1trials
Germany1trials
Italy1trials
Leading interventions
Activation of personal and social resources1trials
Add-on citalopram following optimized methylphenidate1trials
Add-on placebo following optimized methylphenidate1trials
Antidepressants1trials
Bazedoxifene/Conjugated Estrogen1trials
Brainsway H4-Coil Deep TMS System1trials
Brainsway H7-Coil Deep TMS System1trials
Cardiovascular Assessments1trials
Centanafadine1trials
Chinese translated LETS ACT1trials
Chronic Care Model for Mood Disorders1trials
Actigraphy1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.